Clinical Trials Browser

Phase 3 × Triple Negative Breast Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT06627712 2026-01-30

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Phase 3 Recruiting

Triple Negative Breast Neoplasms